Celgene, H. Lee Moffitt Cancer Center cancer news

Moffitt’s M2Gen informatics subsidiary and Celgene launched the Oncology Research Information Exchange Network (ORIEN) Avatar Research Program, a subscription service to generate genetic and clinical information on patients who consent to the Total Cancer Care (TCC) protocol, an observational cancer study. ORIEN is an alliance of U.S. cancer centers co-founded by the Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. ...